Regulation and Function of hTERT in Human Cells
Regulation and Function of hTERT in Human Cells
批准号:
7886303
负责人:
William C. Hahn
金额:
$35.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-15 至 2015-03-31
关键词:
AdultAgeAgingAnimal ModelAnimalsAplastic AnemiaBiochemicalBiochemical GeneticsBiologicalBiologyCartilageCatalytic DomainCell physiologyCellsCellular StressChromatinChromatin StructureChromosomal StabilityComplexDefectDevelopmentDiseaseDouble-Stranded RNADyskeratosis CongenitaEndoribonucleasesFailureFibroblastsFoundationsFundingGTP-Binding ProteinsGenesGenetically Engineered MouseGoalsHairHamman-Rich syndromeHematopoieticHeterochromatinHomeostasisHumanInheritedLengthLinkLongevityMaintenanceMalignant - descriptorMalignant NeoplasmsMammalian CellMitochondrial RNAMolecularMutateMutationNeoplastic Cell TransformationNormal CellOncogene ActivationPathogenesisPatientsPhenotypePlayProcessProtein BindingProteinsRNARNA InterferenceRNA ProcessingRNA-Directed RNA PolymeraseRegulationRibonucleasesRoleSkinSmall Interfering RNAStem cellsStimulusStructureSyndromeTelomeraseTelomere MaintenanceTherapeutic AgentsTissuesWorkbasecancer cellcell transformationendoribonucleasehuman TERT proteininsightloss of functionnovelnovel therapeuticsprotein complexpublic health relevanceregenerativesenescencetelomerase reverse transcriptasetelomeretranslational studytumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomere homeostasis regulates both chromosomal stability and cell replicative lifespan in mammalian cells. As a consequence, alterations in telomere biology play critical roles in the pathogenesis of human cancer and may contribute to aging. Indeed, studies in both human and animal models indicate that telomeres and telomerase, the reverse transcriptase that maintains telomere structure, serve dual roles in oncogenesis, acting both to suppress and facilitate neoplastic transformation. Moreover, mutations of telomerase components required for catalytic activity, TERT and TERC, are found in diseases characterized by stem cell failure including dyskeratosis congenita, subsets of aplastic anemia and idiopathic pulmonary fibrosis. Taken together, these telomerase plays a key role in maintaining telomeres, accumulating evidence suggests that the catalytic observations implicate telomerase as a critical link between cancer and aging. Although it is clear that subunit of TERT contributes to both normal and malignant cell physiology beyond its role in telomere maintenance. Specifically, expression of TERT drives tumor formation under situations when telomere length is not limiting and alters stem cell function in a manner that is independent of the expression of TERC. In prior work, we found that TERT is expressed in cycling primary pre-senescent human fibroblasts and that this low-level expression of telomerase controls proliferative lifespan. During the past funding period, we have investigated the role of TERT in both normal and malignant mammalian cells and found that in addition to its role in telomere maintenance, TERT regulates overall chromatin structure. Moreover, we and others have identified several novel protein complexes that associate with TERT. In recent work, we have found that TERT interacts with the RNA component of mitochondrial RNA processing endoribonuclease (RMRP), a gene that is mutated in the inherited pleiotropic syndrome Cartilage-Hair Hypoplasia. TERT and RMRP form an RNA dependent RNA polymerase (RdRP). These new observations suggest that TERT forms several distinct enzymatic complexes and provide a foundation to understand extra-telomeric functions of TERT. This proposal focuses on investigating the role of these newly identified TERT complexes in senescence and cancer. Specifically, biochemical, genetic and molecular biological approaches will be applied to investigate the role of the TERT-RMRP RdRP in chromatin homeostasis, senescence and transformation, to understand the roles of TERT-RMRP complexes in normal cells and tissues and to elucidate the function of TERT protein complexes in the regulation of senescence. These studies will not only provide new insights into the roles of various TERT complexes in aging and cancer but will also enhance our understanding of heterochromatin regulation. In addition, these studies will provide a foundation for strategies to manipulate these complexes therapeutically.
PUBLIC HEALTH RELEVANCE: Although it is clear that telomeres and telomerase play important roles in aging and cancer, we lack a complete understanding of the roles of telomerase components in senescence and transformation. This proposal focuses on deciphering the role of newly identified TERT complexes in both normal and malignant cells and tissues. These biochemical, cell and animal- based studies will not only provide insight into the biology of TERT complexes but will serve as a foundation for translational studies for the development of novel therapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
-
批准号:10627744
-
项目类别:
-
资助金额:$65.12万
-
财政年份:2022
-
负责人:William C. Hahn
-
依托单位:
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
-
批准号:10046375
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2020
-
负责人:William C. Hahn
-
依托单位:
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
-
批准号:10004385
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2020
-
负责人:William C. Hahn
-
依托单位:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
-
批准号:10250566
-
项目类别:
-
资助金额:$56.84万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
PROJECT 4: Interrogating PP2A Signaling in Human Cancers
-
批准号:9981674
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
-
批准号:10242454
-
项目类别:
-
资助金额:$61.16万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
Systematic identification of oncogenic KRAS synthetic lethal interactions
-
批准号:9330127
-
项目类别:
-
资助金额:$80.78万
-
财政年份:2015
-
负责人:William C. Hahn
-
依托单位:
Systematic identification of oncogenic KRAS synthetic lethal interactions
-
批准号:9150537
-
项目类别:
-
资助金额:$80.78万
-
财政年份:2015
-
负责人:William C. Hahn
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:9362809
-
项目类别:
-
资助金额:$102.74万
-
财政年份:2013
-
负责人:William C. Hahn
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:9979771
-
项目类别:
-
资助金额:$100.76万
-
财政年份:2013
-
负责人:William C. Hahn
-
依托单位:
Discovering modulators of PAX8 for targeting ovarian cancer
-
批准号:8403869
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Identification of TBK1 inhibitors in KRAS-dependent lung cancer
-
批准号:8237125
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Discovering modulators of PAX8 for targeting ovarian cancer
-
批准号:8548405
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Project 2: Identification of combination therapy for KRAS-driven lung cancers.
-
批准号:10231099
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Gene Function Manipulation Core
-
批准号:8233036
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2011
-
负责人:William C. Hahn
-
依托单位:
Druggable Genetic Lesions in Pediatric Astrocytoma
-
批准号:8044508
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2011
-
负责人:William C. Hahn
-
依托单位:
Interactions of the SV40 Small t Antigen and PP2A in Human Cell Transformation
-
批准号:8233031
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8204832
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8408803
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8102937
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: